Use of NSAIDs in the Postoperative Period: Advantage and Disadvantages.
Please respond to the discussion below with a minimum of two paragraphs with two references, APA Style and no plagiarism.
-Nsaids are a commonly used drug that can be bought over the counter without a prescription. NSAIDS are used for patients that have chronic pain, stroke, atherosclerosis and postoperatively this medication is used very commonly. Like all medications Nsaids have risks and benefits. One major risk is bleeding. It is important for patients who are going for surgery to stop this medication the morning of surgery to prevent the risk of bleeding during surgery. NSAIDS are also contraindicated when taking lithium. NSAIDs are known to increase the effects of lithium can can lead to lithium toxicity when taken together. NSAIDs when combined with certain medications can be very dangerous. Nsaids are commonly taken by most people not only geriatrics but also younger population take nsaids for migraine and for menstrual cramps.
Some benefits of Nsaids is that it is easily accessible OYTC and that is very affordable for most people. NSAIDS are very effective for mild to moderate pain. Possible negative side effects include liver and kidney damage, nausea, vomiting and neuropathy. NSAIDs have also been used in combination with chemotherapy drugs in treatment of some cancer. This is now being dispelled and scientists are finding that NSAIDs don’t have any ant cancer causing properties and have now been contraindicated for patients on chemotherapy, the benefits don’t outweigh the cons of taking this drug. Stronger opioids are preferred when treating cancer pain. One benefit of taking an NSAID is that is is not habit forming and there is very low risk of becoming addicted to this medication in comparison to opioids/ narcotics which are extremely addictive and have higher risk of overdose.
Reference
Cosmo, G. D., & Congedo, E. (2015). The Use of NSAIDs in the Postoperative Period: Advantage and Disadvantages. J Anesth Crit Care Open Access, 3(4), 00107.